Psoriasis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

Efficacy and Safety of Apremilast in Psoriasis
Condition:   Psoriasis Intervention:   Drug: Apremilast 30mg Sponsor:   Ghurki Trust and Teaching Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials

A First in Human Study to Evaluate Safety, Tolerability, Pharmacology of HS-10374 in Healthy Subjects
Condition:   Psoriasis Interventions:   Drug: HS-10374 tablets;   Drug: HS-10374-matched placebo tablets Sponsor:   Jiangsu Hansoh Pharmaceutical Co., Ltd. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials

Efficacy and Safety of Apremilast in Psoriasis
Condition:   Psoriasis Intervention:   Drug: Apremilast 30mg Sponsor:   Ghurki Trust and Teaching Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials

A First in Human Study to Evaluate Safety, Tolerability, Pharmacology of HS-10374 in Healthy Subjects
Condition:   Psoriasis Interventions:   Drug: HS-10374 tablets;   Drug: HS-10374-matched placebo tablets Sponsor:   Jiangsu Hansoh Pharmaceutical Co., Ltd. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials

Efficacy and Safety of Apremilast in Psoriasis
Condition:   Psoriasis Intervention:   Drug: Apremilast 30mg Sponsor:   Ghurki Trust and Teaching Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials

A First in Human Study to Evaluate Safety, Tolerability, Pharmacology of HS-10374 in Healthy Subjects
Condition:   Psoriasis Interventions:   Drug: HS-10374 tablets;   Drug: HS-10374-matched placebo tablets Sponsor:   Jiangsu Hansoh Pharmaceutical Co., Ltd. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials

Efficacy and Safety of Apremilast in Psoriasis
Condition:   Psoriasis Intervention:   Drug: Apremilast 30mg Sponsor:   Ghurki Trust and Teaching Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials

A First in Human Study to Evaluate Safety, Tolerability, Pharmacology of HS-10374 in Healthy Subjects
Condition:   Psoriasis Interventions:   Drug: HS-10374 tablets;   Drug: HS-10374-matched placebo tablets Sponsor:   Jiangsu Hansoh Pharmaceutical Co., Ltd. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials

Efficacy and Safety of Apremilast in Psoriasis
Condition:   Psoriasis Intervention:   Drug: Apremilast 30mg Sponsor:   Ghurki Trust and Teaching Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials

A First in Human Study to Evaluate Safety, Tolerability, Pharmacology of HS-10374 in Healthy Subjects
Condition:   Psoriasis Interventions:   Drug: HS-10374 tablets;   Drug: HS-10374-matched placebo tablets Sponsor:   Jiangsu Hansoh Pharmaceutical Co., Ltd. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials

Efficacy and Safety of Apremilast in Psoriasis
Condition:   Psoriasis Intervention:   Drug: Apremilast 30mg Sponsor:   Ghurki Trust and Teaching Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials

A First in Human Study to Evaluate Safety, Tolerability, Pharmacology of HS-10374 in Healthy Subjects
Condition:   Psoriasis Interventions:   Drug: HS-10374 tablets;   Drug: HS-10374-matched placebo tablets Sponsor:   Jiangsu Hansoh Pharmaceutical Co., Ltd. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 12, 2023 Category: Research Source Type: clinical trials

Efficacy and Safety of Apremilast in Psoriasis
Condition:   Psoriasis Intervention:   Drug: Apremilast 30mg Sponsor:   Ghurki Trust and Teaching Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 12, 2023 Category: Research Source Type: clinical trials